Mobility wk 11 Flashcards
Parathyroid hormone and Ca++ feedback loop
Low serum Ca++
Parathyroid gland releases PTH»_space;
- Ca++ release from bone, incr
- Ca++ reabsorption from kidneys
- incr Ca++ absorption in sm intestine (with help of Vit D & calcitriol)
Incr serum Ca++
PTH release suppressed
Calcitonin and Ca++ feedback loop
High serum Ca++
Thyroid gland releases calcitonin»_space;
- addition of Ca++ to bone
- decr absorption of Ca++ in sm intestine
Low serum Ca++
Calcitonin release suppressed
Lack of dietary Ca++
leads to bone breakdown to incr serum Ca++
Needed for muscle fx
RANKL
Hormone that increases bone loss
Osteoporosis drugs target this to decr bone loss
Should be in balance w/ OPG
OPG
Hormone that decrease bone loss
Should be in balance w/ RANKL
Osteoporosis risk and gender
Women @ incr risk (esp. menopausal)»_space; decr estrogen = incr renal excretion of Ca++
Women more likely to frac hip that get breast/ovarian cx
Men start out w/ higher bone density d/t androgens and testoterone
General osteoporosis risk factors
Female, low estrogen, Depo-Provera Small boned, thin Hyperthyroid (Ca++ control in thyroids) Smoking, etoh Low impact exercise lifestyle On chronic corticosteroids (pts w/ RA, lung dx on prednisone & at risk) Kidney, liver dx
Pts at risk for osteoporosis
Vit C, D deficiencies Malabsorption (ulcerative colitis) Hist. of excessive caffeine, etoh, nicotine Non-wt bearing Thyroid disorders Kidney dx Estrogen deficiency
Posture suggesting bone dx
Scoliosis
Kyphosis
Lordosis
Compression fractures
Pts w/ osteoporosis at risk for
Doesn’t take much force
New onset of back pain w/o traumatic even may indicate
Vitamin D
D2 is from dietary sources
D3 is from sunlight
- incr absorption of Ca++ from GI tract
- decr renal excretion of Ca++
- activation is determined by Ca++ avail
Blood serum levels: 18-80 ng/mL
- low levels seen in osteoporosis, malabsorption prob, CKD, liver dx
Proteoglycans
Needed for production of synovial fluid
Why are weight bearing activities important
Triggers the body to deposit more Ca++ in bone
Drugs from bone disorders
Ca++ supplement Vit D Bisphosphonates (fosamax) Selective estrogen receptor modulators Calcitonin HRT PTH analog
alendronate (Fosamax)
Bisphosphonate, bone metabolism regulator
MOA: Minimize loss of bone density, decr #/activity of osteoclast
Route & dose: PO, 5-10 mg 1x/d
Contra: GERD, esophageal prob
Caution: renal impairment
ADR: hypocalcemia, esophageal ulceration, N/V, atypical femoral fractures (sx: ext rotation of foot will cause pain)
Nrs: assess swallow (esoph. prob)
Edu: take w/ fluids, avoid lying down for 30 mins, report persistent joint pain
Take 30 min b4 food: Ca++ and food decr
absorption